Venture Capital Archives - Page 111 of 111 - Boston Life Sciences Times

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

March 10, 2026

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

THIS WEEK'S STORIES

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

March 5, 2026

Liberate Bio Licenses Myeloid-Optimized CAR Designs to Advance In Vivo CAR-M Therapies

March 5, 2026

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

March 4, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Cambridge Startup Axiomatic AI Raises $18M to Build Verified AI Platform for Engineering

Cognito Therapeutics Raises $105 Million Series C to Advance Alzheimer’s Therapy Platform

Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases

BreezeBio Raises $60 Million in Series B to Advance Precision Genetic Medicines Pipeline

Synthpop Raises $15 Million Series A to Expand AI Platform for Healthcare Workflow Automation

Most Read

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

GoTo Launches AI-Powered Patient Communications Platform for Clinics and Multi-Location Practices

Newton Women’s Health Company Reports Study Showing Leva Device Improves Fecal Incontinence Symptoms

Study Suggests Daily Multivitamin May Slow Biological Aging

EDITOR PICKS

Casma Therapeutics Secures $7.6 Million in MJFF Funding to Advance Parkinson’s Disease Program

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

THIS WEEK'S STORIES

NEJM Publishes Data Suggesting Zorevunersen May Modify Disease Course in Dravet Syndrome

Liberate Bio Licenses Myeloid-Optimized CAR Designs to Advance In Vivo CAR-M Therapies

Arsenal Medical Treats First Patient with ResQFoam Device for Life-Threatening Abdominal Bleeding

POPULAR CATEGORY

ABOUT US

FOLLOW US